Clostridium difficile - Associated disease: Diagnosis, prevention, treatment, and nursing care

Critical Care Nurse

Volumn 28, Issue 1, 2008, Pages 27-35

  Pelleschi, Maria E ^a,b  

^a St Vincent Charity Hospital   (United States)

^b Bryant and Stratton College   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; PROBIOTIC AGENT;

CLOSTRIDIUM DIFFICILE; CROSS INFECTION; DECUBITUS; DEHYDRATION; HAND WASHING; HOSPITALIZATION; HUMAN; INFECTION CONTROL; INTENSIVE CARE; MICROBIOLOGY; NURSE ATTITUDE; NURSING ASSESSMENT; ORGANIZATION AND MANAGEMENT; PATIENT CARE; PATIENT CARE PLANNING; PSEUDOMEMBRANOUS COLITIS; REVIEW; RISK FACTOR;

ANTI-INFECTIVE AGENTS; CLOSTRIDIUM DIFFICILE; CRITICAL CARE; CROSS INFECTION; DEHYDRATION; ENTEROCOLITIS, PSEUDOMEMBRANOUS; HANDWASHING; HUMANS; INFECTION CONTROL; NURSE'S ROLE; NURSING ASSESSMENT; PATIENT CARE PLANNING; PATIENT ISOLATION; PRESSURE ULCER; PROBIOTICS; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 55249087723     PISSN: 02795442     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. McDonald LC, Owings M, Jerigan DB. Clostridium difficile infection in patients discharged from US short-stay hospitals, 1996-2003. Emerg Infect Dis. 2006;12(3):409-415. http://www.cdc.gov/ncidod/EID/ vol12no03/05-1064.htm. Accessed November 26, 2007.
2. Centers for Disease Control and Prevention. Clostridium difficile information for healthcare providers: FAQ: CDC infection control. 2005. http://www.cdc.gov/ncidod/dhqp/id_CdiffFAQ_HCP.html. Accessed November 26, 2007.
3. Ohio Department of Health. Clostridium difficile. 2006. http://www.odh.state.oh.us/pdf/idcm/clostdif.pdf#search= %22incidence%20CDAD%20Ohio%20Department%20of%20health%22. Accessed November 26, 2007.
4. Kyne L, Hamel MB, Polavaram R, et al. Health care costs and mortality associated with nosocomial diarrhea due to Clostridium difficile. Clin Infect Dis. 2002;34(3):346-353.
5. Sunenshine RH, McDonald LC. Clostridium difficile-associated disease: new challenges from an established pathogen. Cleve Clin J Med. 2006;73(2):187-197.
6. Pepin J, Saheb N, Coulombe MA, et al. Emergence of floroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhea: a corhort study during an epidemic in Quebec. Clin Infect Dis. 2005;41(9):1254-1260.
7. Loo VG, Libman MD, Miller MA, et al. Clostridium difficile: a formidable foe. CMAJ. 2006;171(1):47-48
8. Murray PR, Rosenthal KS, Pfaller AM. Medical Microbiology. 5th ed. Philadelphia, PA: Elsevier Mosby; 2005:411-413.
9. Dial S, Alrasadi K, Manoukian C, Huang A, et al. Risk of Clostridium difficile diarrhea among inpatients prescribed proton pump inhibitors: cohort and case-control studies. CMAJ. 2004;171(1):33-38.
10. Poutanen SM, Simor AE. Clostridium difficile-associated diarrhea in adults. CMAJ. 2004;171(1):51-58.
11. Schroeder MS. Clostridium difficile-associated diarrhea. Am Fam Physician. 2005;71(5):921-928. http://www.aafp.org/afp/20050301/ 921.pdf. Accessed November 26, 2007.
12. Perloff S, Horn D. Community-acquired Clostridium difficile colitis. Emerg Med. 2007;39(7):37-42. http://www.emedmag.com/html/pre/fea/ features/039070037.asp. Accessed November 26, 2007.
13. Grainger M. A staff nurse's perspective of infection control problems. Br J Nurs. 2005; 14(17):912-916.
14. Bartlett JG. New drugs for Clostridium difficile infection. Clin Infect Dis. 2006;43(4): 428-431.
15. Apisarnthanarak A, Mundy LM. Intracolonic vancomycin for adjunctive treatment of severe Clostridium difficile colitis: indications and precautions. J Infect Dis Antimicrob Agents. 2005;22(1):21-26.
16. Lagrotteria D, Holmes S, Smieja M, Smaill F, Lee C. Prospective, randomized inpatient study of oral metronidazole versus oral metronidazole and rifampin for treatment of primary episodes of Clostridium difficile-associated diarrhea. Clin Infect Dis. 2006; 43(5):547-552.
17. Musher DM, Logan N, Hamill RJ, et al. Nitazoxanide for the treatment of Clostridium difficile colitis. Clin Infect Dis. 2006; 43(4):421-427.
18. Louie TJ, Peppe J, Watt CK, et al. Tolevamer, a novel nonantibiotic polymer, compared with vancomycin in the treatment of mild to moderately severe Clostridium difficile-associated diarrhea. Clin Infect Dis. 2006; 43(4):411-420.
19. Wilcox MH. Descriptive study of intravenous immunoglobulin for the treatment of recurrent Clostridium difficile diarrhoea. J Antimicrob Chemother. 2004;53(5):882-884.
20. Dendukuri N, Costa V, McGregor M, et al. Probiotic therapy for the prevention and treatment of Clostridium difficile diarrhea: a systematic review. CMAJ. 2005;173(2): 167-170.
21. Boutros M, Ladouceur M, Rahme E, Lamoureux E, Vasilevsky CA. Timing of total abdominal colectomy and risk factors predictive of mortality for fulminant Clostridium difficile colitis [abstract]. Can J Surg. 2006; 49(suppl):24.
22. Fordtran JS. Colitis due to Clostridium difficile toxins: underdiagnosed, highly virulent, and nosocomial. Proc (Bayl Univ Med Cent). 2006;19(1):3-12.
23. Pimentel RR. Antibiotic-associated diarrhea. The Cleveland Clinic: Medicine Index. 2003.http://www.clevelandclinicmeded.com/ diseasemanagement/gastro/antibioticdiarrhea/antibioticdiarrhea.htm. Accessed November 26, 2007.
24. Fisher JA, Fikry C, Troxel AB. Cutting cost and increasing access to colorectal cancer screening: another approach to following the guidelines. Cancer Epidemiol Biomarkers Prev. 2006;15(1):108-113.
25. Todor K. Todor's Online Book of Bacteriology. 2006. http://textbookofbacteriology.net/clostridia.html. Accessed November 26, 2007.
26. Lam BC, Lee J, Lau YL. Hand hygiene practices in a neonatal intensive care unit: a multimodal intervention and impact on nosocomial infection. Pediatrics. 2004;114(5):e565-e571.
27. Parish C. New commodes and mattresses lead to dramatic fall in infections. Nurs Stand. 2007;21(41):11.
28. Aas J, Gessert CE, Bakken JS. Recurrent Clostridium difficile colitis: case series involving 18 patients treated with donor stool administered via a nasogastric tube. Clin Infect Dis. 2003;36(5):580-585.
29. Ohl ME, Stevermer JJ, Meadows S. What are the effective therapies for Clostridium difficile-associated diarrhea? J Fam Pract. 2005;54(2):176-178.
30. Chico GF, Chico MA. Clostridium difficile colitis. Emerg Med. 2005;37(1): 27-32. http://www.emedmag.com/html/pre/gic/consults/ 011505.asp. Accessed November 26, 2007.
31. McFarland LV. Alternative treatments for Clostridium difficile disease: what really works? J Med Microbiol. 2005;54(pt 2):101-111.
32. Sullivan A, Nord CE. Probiotics and gastrointestinal disease. J Intern Med. 2005;257(1):78-92.
33. Cavagnaro C, Berezin S, Medow MS. Corticosteroid treatment of severe, non-responsive Clostridium difficile induced colitis. Arch Dis Child. 2003; 88(4):342-344.
34. Ignatavicius D, Workman M. Medical-Surgical Nursing: Critical Thinking for Collaborative Care. St Louis, MO: Elsevier Saunders; 2006:1429, 217-219.
35. Ackley BJ, Ladwig, GB. Nursing Diagnosis Handbook. 7th ed. St. Louis, MO: Mosby Elsevier; 2006:1125-1131.
36. Rees J, Davies H, Birchall C, Price J. Psychological effects of source isolation nursing, 2: patient satisfaction. Nurs Stand. 2000;14(29):32-36.
37. George-Gay B, Chernecky CC. Clinical Medical-Surgical Nursing: A Decision-Making Reference. Philadelphia, PA: WB Saunders Co; 2002:519-524.
38. Driver DS. Perineal dermatitis in critical care. Crit Care Nurse. 2007;27(4):42-46.
39. Convatec, A Brystol-Meyer Squibb Company. Healthcare professionals: Flexi-Seal Fecal Management System. 2007. http://www.convatec.com/ index.html. Accessed November 26, 2007.